Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?

Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
复制标题

DOI:
10.1007/s13311-021-01081-y
复制
发表时间:
2021-07
期刊:
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
影响因子:
--
通讯作者:
Lignani G
Lignani G
中科院分区:
其他
文献类型:
--
作者:
Carpenter JC;Lignani G

文献摘要

参考文献

被引文献

相似文献

癫痫是一种复杂的神经系统疾病,有大量的单基因亚型。单基因癫痫通常是严重且致残的,具有耐药性癫痫发作和严重的发育合并症的特征。这些疾病可能适用于精准医学方法,其中使用 CRISPR/Cas 进行基因组编辑是其中的圣杯。在这里,我们考虑一些最“常见”的罕见癫痫基因的突变,并讨论可用于治疗这些疾病的不同 CRISPR/Cas 方法。我们考虑了 CRISPR 介导的基因调节可以作为有效治疗策略的情况,并讨论了单基因纠正方法是否可以在发育中的、高度动态的大脑的稳态补偿背景下具有治疗潜力。 尽管对遗传性癫痫的机制尚不完全了解,而且目前基因编辑工具的局限性,但 CRISPR 介导的方法在未来十年的遗传性癫痫治疗中具有改变游戏规则的潜力。在线版本包含可在 10.1007/s13311-021-01081-y 获取的补充材料。
Epilepsy is a complex neurological disorder for which there are a large number of monogenic subtypes. Monogenic epilepsies are often severe and disabling, featuring drug-resistant seizures and significant developmental comorbidities. These disorders are potentially amenable to a precision medicine approach, of which genome editing using CRISPR/Cas represents the holy grail. Here we consider mutations in some of the most ‘common’ rare epilepsy genes and discuss the different CRISPR/Cas approaches that could be taken to cure these disorders. We consider scenarios where CRISPR-mediated gene modulation could serve as an effective therapeutic strategy and discuss whether a single gene corrective approach could hold therapeutic potential in the context of homeostatic compensation in the developing, highly dynamic brain. Despite an incomplete understanding of the mechanisms of the genetic epilepsies and current limitations of gene editing tools, CRISPR-mediated approaches have game-changing potential in the treatment of genetic epilepsy over the next decade. The online version contains supplementary material available at 10.1007/s13311-021-01081-y.
进行性肌阵癫痫KCNC1变体引起发育性树突病。
DOI: 10.1111/epi.16867
发表时间: 2021-05
期刊: Epilepsia
影响因子: 5.6
作者:
Carpenter JC;Männikkö R;Heffner C;Heneine J;Sampedro-Castañeda M;Lignani G;Schorge S
通讯作者: Schorge S
DOI: 10.1038/s41588-019-0538-0
发表时间: 2019-12-01
期刊: NATURE GENETICS
影响因子: 30.8
作者:
Fulco, Charles P.;Nasser, Joseph;Engreitz, Jesse M.
通讯作者: Engreitz, Jesse M.
DOI: 10.1038/s41591-019-0608-y
发表时间: 2019-11-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Chen, Chien-Ju;Sgritta, Martina;Costa-Mattioli, Mauro
通讯作者: Costa-Mattioli, Mauro
DOI: 10.1007/s00401-019-02061-5
发表时间: 2019-12-01
影响因子: 12.7
作者:
Baldassari, Sara;Ribierre, Theo;Baulac, Stephanie
通讯作者: Baulac, Stephanie
DOI: 10.1093/brain/awy051
发表时间: 2018-04-01
期刊: Brain : a journal of neurology
影响因子: --
作者:
Fruscione F;Valente P;Sterlini B;Romei A;Baldassari S;Fadda M;Prestigio C;Giansante G;Sartorelli J;Rossi P;Rubio A;Gambardella A;Nieus T;Broccoli V;Fassio A;Baldelli P;Corradi A;Zara F;Benfenati F
通讯作者: Benfenati F